US Stocks
/
Damora Therapeutics, Inc. Share Price

Damora Therapeutics, Inc. Share Price

NASDAQ: DMRA | Micro Cap
$21.11
-$0.74 (-3.36%) Last updated on 24 Oct, 2026 | 01:20 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Damora Therapeutics, Inc. Stock Performance

Open
$20.73
Prev. Close
$21.85
Circuit Range
N/A
Day Range
$20.47 - $21.08
Year Range
$16.59 - $34.87
Volume
18,901
Average Traded
$20.79

Damora Therapeutics, Inc. Share Price Today

As of 24 October 2026, Damora Therapeutics, Inc.'s share price is $21.11. The stock opened at $20.73, compared to its previous close of $21.85. During today's trading session, Damora Therapeutics, Inc.'s share price traded between $20.47 and $21.08, with an average price of $20.77. Over the past 52 weeks, the stock has recorded a high of $34.87 and a low of $16.59. In terms of performance, Damora Therapeutics, Inc.'s share price has declined by 17.82% over the last six months and is down 18.51% on a year-on-year basis.

Damora Therapeutics, Inc. Share Price Chart

$20.47$21.08
L
Show Current Price
H

Damora Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$28.78M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.73
Revenue (TTM)
N/A
Return On Equity (TTM)
-8.69%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
N/A

Damora Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsMar 2026Jun 2026
Revenue$0.00$0.00
Net Profit-$21.33-$24.06
Net Profit MarginN/AN/A
Income ChangeN/A-12.80%

About Damora Therapeutics, Inc.

Damora Therapeutics Inc is a biotechnology company that aims to fundamentally redefine care for people with hematologic disorders. The group is advancing a new generation of biologics to treat mutant calreticulin-driven myeloproliferative neoplasms, including essential thrombocythemia and myelofibrosis, where there is cruicial medical need for disease-modifying treatments. Its goal is to rapidly bring forward optimized therapies with broad mutation coverage and exceptional convenience to dramatically improve patient outcomes. The group's pipeline products are DMR-001, DMR-002, DMR-003, and GB3226.

Damora Therapeutics, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$20.77
$21.08
-1.45%
Sep 2026
$28.00
$21.39
-30.05%
Aug 2026
$29.41
$30.58
+5.50%
Jul 2026
$26.34
$28.98
+11.61%
Jun 2026
$25.83
$25.97
+4.17%
May 2026
$26.09
$24.93
-2.98%
Apr 2026
$26.48
$25.70
-0.83%
Mar 2026
$27.93
$25.91
N/A

DMRA Share Price FAQs

What is Damora Therapeutics, Inc. share price today?

chevron-up
Damora Therapeutics, Inc. share price today is $21.11 as on October 24, 2026 at 1:20 am IST.

What is the 52 week high and 52 week low of Damora Therapeutics, Inc. stock?

chevron-up
The 52 week high of Damora Therapeutics, Inc. stock is $34.87, while the 52 week low is $16.59 as of 24 Oct '26.

What is DMRA's market capitalisation today?

chevron-up
DMRA market capitalisation is $28.78M as of October 24, 2026, at 1:20 am IST.

What is DMRA's net income for the last quarter?

chevron-up
DMRA's net income for the last quarter is -24.06B USD.

What is the 5 year returns of DMRA?

chevron-up
The 5 year returns of DMRA is -18.51% as on 24 Oct '26.

What is the high & low stock price of DMRA today?

chevron-up
DMRA stock price hit a high of $21.08 and low of $20.47 as of 24 Oct '26.

Can I buy DMRA shares in India?

chevron-up
Yes. You can buy DMRA in India by opening an international trading account.